INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,545,965 | +55.1% | 48,892 | +100.0% | 0.00% | +100.0% |
| Q2 2023 | $996,908 | -10.2% | 24,446 | -17.9% | 0.00% | 0.0% |
| Q1 2023 | $1,109,565 | -35.7% | 29,771 | -39.8% | 0.00% | -50.0% |
| Q4 2022 | $1,725,276 | -31.1% | 49,449 | +9.2% | 0.00% | -33.3% |
| Q3 2022 | $2,503,000 | +7.7% | 45,271 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $2,323,000 | -37.7% | 44,877 | -12.5% | 0.00% | 0.0% |
| Q1 2022 | $3,728,000 | -45.2% | 51,295 | -10.9% | 0.00% | -50.0% |
| Q4 2021 | $6,805,000 | -7.5% | 57,549 | +5.0% | 0.01% | -25.0% |
| Q3 2021 | $7,355,000 | -7.3% | 54,830 | -2.0% | 0.01% | 0.0% |
| Q2 2021 | $7,934,000 | +92.1% | 55,930 | +8.6% | 0.01% | +60.0% |
| Q1 2021 | $4,131,000 | +64.3% | 51,479 | +11.4% | 0.01% | +66.7% |
| Q4 2020 | $2,515,000 | +225.8% | 46,229 | +19.0% | 0.00% | +200.0% |
| Q3 2020 | $772,000 | +6.3% | 38,857 | +12.4% | 0.00% | 0.0% |
| Q2 2020 | $726,000 | – | 34,557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |